The FDA, Juno Therapeutics, and the ethical imperative of transparency.

Persons

Aaron Seth Kesselheim

Venue / Journal

BMJ

Date

Mon, 08/15/2016 - 12:00

Additional Journal Information

354:i4435

Authors

Hey SP, Kesselheim AS.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/27526698